Fundraising Fox

Allakos Inc

San Carlos, US · Founded 2012 · Delaware corporation · 5 known investors

Portfolio company that completed a successful 2018 biotech IPO, resulting in a 9x return for RiverVest.

Biotech

Founders & leadership

Allakos Inc was founded in 2012 by Nenad Tomasevic and Christopher Bebbington.

NT
Nenad TomasevicCo-founder
CB
Christopher BebbingtonCo-founder
AD
Alejandro DorenbaumExecutive

Board

FCFarah Champsi
Farah ChampsiinBoard directorManaging Partner at Alta Partners
JMJohn McKearn
John McKearnin𝕏Board directorSenior Advisor at RiverVest Venture Partners, focused on early-stage biotech
PM
Peter MoldtBoard director

Investors · 5

Alta PartnersJackson · $1M – $12Mvia Farah Champsi · board
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
RiverVest Venture PartnersSt. Louis · $500K – $3M
Samsara BioCapitalPalo Alto
Roche Venture FundreportedBasel · $648K – $3.2M

Reported raises · per SEC filings

Form D private placements

$128.1M disclosed across 2 rounds · 2012–2017

▶$100.1MraisedDec 2017 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dan JanneyDirector
  • John McKearnDirector
  • Robert AlexanderExecutive Officer, Director
  • Adam TomasiExecutive Officer
  • Steve JamesDirector
  • Paul WalkerDirector
Offering amount
$100.1M
Amount sold
$100.1M
First sale
Nov 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.9MraisedMar 2015 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Nenad TomasevicExecutive Officer
  • Farah ChampsiDirector
  • Alejandro DorenbaumExecutive Officer
  • John McKearnDirector
  • Peter MoldtDirector
  • Christopher BebbingtonExecutive Officer, Director
Offering amount
$47M
Amount sold
$27.9M
First sale
Dec 2012
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Allakos Inc. (ALLK): history, ownership, mission, how it works & makes money – DCFmodeling.comdcfmodeling.com · Jun 2024Bay Area Startup Allakos Locks In Another $10 Million - BioSpacebiospace.com · Sep 2014Allakos Inc. Raises Additional $10 Million to Expand its Portfolio and Fund Development of an Additional Antibody for Allergic and Inflammatory Diseasesprnewswire.com · Sep 2014Buy Allakos Inc Stock – ALLK Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

What does Allakos Inc do?
Portfolio company that completed a successful 2018 biotech IPO, resulting in a 9x return for RiverVest.
Who founded Allakos Inc?
Allakos Inc was founded by Nenad Tomasevic, Christopher Bebbington in 2012.
Who are Allakos Inc's investors?
Allakos Inc's investors include Alta Partners, New Enterprise Associates (NEA), RiverVest Venture Partners, Samsara BioCapital, Roche Venture Fund.
How much funding has Allakos Inc raised?
Allakos Inc has disclosed $128.1M raised across 2 rounds.
Where is Allakos Inc headquartered?
Allakos Inc is headquartered in San Carlos, US.